| 序号 | 股票代码 | 股票名称 | 机构名称 | 变动方向 | 变动股份数(股) | 变动后数量(股) | 变动后持股率 | 公布日期 |
| 51 | 02235 | 微泰医疗-B | Invesco Advisers, Inc. |
增持 | 2.03万 | 1117.95万 | 17.00% | 2021-11-19 |
| 52 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
减持 | -952.94万 | 43.70万 | 0.66% | 2021-11-15 |
| 53 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
减持 | -952.94万 | 43.70万 | 0.66% | 2021-11-15 |
| 54 | 02235 | 微泰医疗-B | Invesco Advisers, Inc. |
增持 | 4.70万 | 1112.28万 | 16.91% | 2021-11-15 |
| 55 | 02235 | 微泰医疗-B | Goldman Sachs Holdings (Asia Pacific) Limited |
减持 | -952.94万 | 0.00万 | 0.00% | 2021-11-10 |
| 56 | 02235 | 微泰医疗-B | Goldman Sachs (Asia) L.L.C. |
减持 | -952.94万 | 0.00万 | 0.00% | 2021-11-10 |
| 57 | 02235 | 微泰医疗-B | Goldman Sachs (Asia) Corporate Holdings L.L.C. |
减持 | -952.94万 | 0.00万 | 0.00% | 2021-11-10 |
| 58 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
减持 | -731.63万 | 996.64万 | 15.69% | 2021-11-10 |
| 59 | 02235 | 微泰医疗-B | Goldman Sachs Holdings (Hong Kong) Limited |
减持 | -952.94万 | 0.00万 | 15.00% | 2021-11-10 |
| 60 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
增持 | 7.73万 | 1721.40万 | 27.10% | 2021-11-09 |
| 61 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
增持 | 43.01万 | 1694.19万 | 26.67% | 2021-11-05 |
| 62 | 02235 | 微泰医疗-B | Invesco Developing Markets Fund |
增持 | 19.83万 | 971.18万 | 15.28% | 2021-11-04 |
| 63 | 02235 | 微泰医疗-B | Invesco Advisers, Inc. |
增持 | 22.12万 | 1080.94万 | 17.01% | 2021-11-04 |
| 64 | 02235 | 微泰医疗-B | The Bank of New York Mellon Corporation |
减持 | -281.56万 | 207.96万 | 3.27% | 2021-11-03 |
| 65 | 02235 | 微泰医疗-B | The Bank of New York Mellon Corporation |
增持 | 489.01万 | 489.52万 | 7.71% | 2021-11-02 |
| 66 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
增持 | 18.37万 | 1588.97万 | 25.01% | 2021-11-01 |
| 67 | 02235 | 微泰医疗-B | FMR LLC |
减持 | -5.13万 | 377.37万 | 5.94% | 2021-10-28 |
| 68 | 02235 | 微泰医疗-B | The Bank of New York Mellon Corporation |
减持 | -490.20万 | 0.49万 | 0.01% | 2021-10-28 |
| 69 | 02235 | 微泰医疗-B | Invesco Advisers, Inc. |
增持 | 11.87万 | 1026.43万 | 16.15% | 2021-10-28 |
| 70 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
增持 | 26.92万 | 1533.00万 | 24.13% | 2021-10-27 |
| 71 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
增持 | 43.58万 | 1499.17万 | 23.60% | 2021-10-26 |
| 72 | 02235 | 微泰医疗-B | The Bank of New York Mellon Corporation |
增持 | 467.12万 | 467.53万 | 7.36% | 2021-10-25 |
| 73 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
增持 | 62.80万 | 1421.01万 | 22.37% | 2021-10-21 |
| 74 | 02235 | 微泰医疗-B | Invesco Developing Markets Fund |
增持 | 62.01万 | 898.64万 | 14.14% | 2021-10-20 |
| 75 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
增持 | 177.10万 | 1358.21万 | 21.38% | 2021-10-20 |
| 76 | 02235 | 微泰医疗-B | Invesco Advisers, Inc. |
增持 | 69.29万 | 994.20万 | 15.64% | 2021-10-20 |
| 77 | 02235 | 微泰医疗-B | Coatue Management, L.L.C. |
增持 | 332.50万 | 332.50万 | 5.23% | 2021-10-19 |
| 78 | 02235 | 微泰医疗-B | China International Capital Corporation (Hong Kong) Limited |
增持 | 419.29万 | 419.29万 | 6.60% | 2021-10-19 |
| 79 | 02235 | 微泰医疗-B | China International Capital Corporation Hong Kong Securities Limited |
增持 | 419.29万 | 419.29万 | 6.60% | 2021-10-19 |
| 80 | 02235 | 微泰医疗-B | China International Capital Corporation Limited |
增持 | 419.29万 | 419.29万 | 6.60% | 2021-10-19 |
| 81 | 02235 | 微泰医疗-B | Morgan Stanley |
增持 | 651.64万 | 651.64万 | 10.25% | 2021-10-19 |
| 82 | 02235 | 微泰医疗-B | Goldman Sachs (Asia) Corporate Holdings L.L.C. |
增持 | 952.94万 | 952.94万 | 15.00% | 2021-10-19 |
| 83 | 02235 | 微泰医疗-B | Morgan Stanley & Co. International plc |
增持 | 317.88万 | 317.88万 | 5.00% | 2021-10-19 |
| 84 | 02235 | 微泰医疗-B | Goldman Sachs (Asia) L.L.C. |
增持 | 952.94万 | 952.94万 | 15.00% | 2021-10-19 |
| 85 | 02235 | 微泰医疗-B | Goldman Sachs Holdings (Asia Pacific) Limited |
增持 | 952.94万 | 952.94万 | 15.00% | 2021-10-19 |
| 86 | 02235 | 微泰医疗-B | Goldman Sachs Holdings (Hong Kong) Limited |
增持 | 952.94万 | 952.94万 | 15.00% | 2021-10-19 |
| 87 | 02235 | 微泰医疗-B | Morgan Stanley & Co. LLC |
增持 | 333.76万 | 333.76万 | 5.25% | 2021-10-19 |
| 88 | 02235 | 微泰医疗-B | Morgan Stanley Capital Management, LLC |
增持 | 333.76万 | 333.76万 | 5.25% | 2021-10-19 |
| 89 | 02235 | 微泰医疗-B | Morgan Stanley Domestic Holdings, Inc. |
增持 | 333.76万 | 333.76万 | 5.25% | 2021-10-19 |
| 90 | 02235 | 微泰医疗-B | Morgan Stanley International Holdings Inc. |
增持 | 317.88万 | 317.88万 | 5.00% | 2021-10-19 |
| 91 | 02235 | 微泰医疗-B | Morgan Stanley International Limited |
增持 | 317.88万 | 317.88万 | 5.00% | 2021-10-19 |
| 92 | 02235 | 微泰医疗-B | Morgan Stanley Investments (UK) |
增持 | 317.88万 | 317.88万 | 5.00% | 2021-10-19 |
| 93 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
增持 | 228.17万 | 1181.11万 | 18.59% | 2021-10-19 |
| 94 | 02235 | 微泰医疗-B | The Goldman Sachs Group, Inc. |
增持 | 952.94万 | 952.94万 | 15.00% | 2021-10-19 |
| 95 | 02235 | 微泰医疗-B | Matthews International Capital Management, LLC |
增持 | 520.00万 | 520.00万 | 8.18% | 2021-10-19 |
| 96 | 02235 | 微泰医疗-B | UBS Fund Management (Luxembourg) S.A. |
增持 | 630.56万 | 630.56万 | 9.93% | 2021-10-19 |
| 97 | 02235 | 微泰医疗-B | Invesco Advisers, Inc. |
增持 | 924.91万 | 924.91万 | 14.55% | 2021-10-19 |
| 98 | 02235 | 微泰医疗-B | Invesco Developing Markets Fund |
增持 | 836.63万 | 836.63万 | 13.16% | 2021-10-19 |
| 99 | 02235 | 微泰医疗-B | UBS Group AG |
增持 | 747.43万 | 747.43万 | 11.77% | 2021-10-19 |
